BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2429796)

  • 1. Growth hormone releasing hormone.
    Grossman A; Savage MO; Besser GM
    Clin Endocrinol Metab; 1986 Aug; 15(3):607-27. PubMed ID: 2429796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature.
    Grossman A; Savage MO; Blacklay A; Ross RM; Plowman PN; Preece MA; Coy DH; Besser GM
    Horm Res; 1985; 22(1-2):52-7. PubMed ID: 2863206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
    Achermann JC; Hindmarsh PC; Robinson IC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):575-85. PubMed ID: 10594518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults.
    Grossman A; Savage MO; Lytras N; Preece MA; Sueiras-Diaz J; Coy DH; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):321-30. PubMed ID: 6236914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
    Ross RJ; Rodda C; Tsagarakis S; Davies PS; Grossman A; Rees LH; Preece MA; Savage MO; Besser GM
    Lancet; 1987 Jan; 1(8523):5-8. PubMed ID: 2879138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of 24-hour growth hormone secretion after continuous subcutaneous infusion of growth hormone-releasing hormone (GHRH (1-29)NH2) in short children with low 24-hour growth hormone secretion.
    Tauber MT; Pienkowski C; Landier F; Gunnarsson R; Rochiccioli P
    Acta Paediatr Scand Suppl; 1989; 349():117-22; discussion 123-4. PubMed ID: 2546370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release.
    Blacklay A; Grossman A; Ross RJ; Savage MO; Davies PS; Plowman PN; Coy DH; Besser GM
    J Endocrinol; 1986 Jan; 108(1):25-9. PubMed ID: 2868066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat.
    Park S; Sohn S; Kineman RD
    J Endocrinol; 2004 Mar; 180(3):369-78. PubMed ID: 15012591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term pulsatile growth hormone (GH)-releasing hormone therapy in children with GH deficiency.
    Low LC; Wang C; Cheung PT; Ho P; Lam KS; Young RT; Yeung CY; Ling N
    J Clin Endocrinol Metab; 1988 Mar; 66(3):611-7. PubMed ID: 3127420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
    Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone-releasing hormone. The physiopathologic aspects and its diagnostic-therapeutic use].
    De Marinis L; Mancini A; La Brocca A; D'Amico C; Sambo P; Tofani A; Barbarino A
    Minerva Med; 1989 Apr; 80(4):325-34. PubMed ID: 2566960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.